NKF

HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences

Retrieved on: 
Wednesday, April 17, 2024

Pentavere will be presenting at the following medical conferences:

Key Points: 
  • Pentavere will be presenting at the following medical conferences:
    Canadian Retina Society Annual Meeting on May 3-5, 2024 in Montreal, QC.
  • American Medical Informatics Association (AMIA) Clinical Informatics Conference on May 21-23, 2024 in Minneapolis, MN.
  • Presenting Research: Using Artificial Intelligence to automate the extraction of staging criteria from the electronic health records of oropharyngeal cancer patients.
  • Thought leaders driving the future of healthcare delivery will explore practice-ready solutions to enhance patient experiences, reduce costs, and improve public health.

The National Kidney Foundation Urges Passage of New Home Dialysis Bill

Retrieved on: 
Tuesday, April 23, 2024

WASHINGTON, April 23, 2024 /PRNewswire/ -- The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis. The Improving Access to Home Dialysis Act (HR-8075) was introduced today in the U.S. House of Representatives by Reps. Carol Miller (R-WV), Marilyn Strickland (D-WA), Earl Blumenauer (D-OR), and Mariannette Miller-Meeks (R-IA). A companion bill is expected to be introduced soon in the Senate.

Key Points: 
  • WASHINGTON, April 23, 2024 /PRNewswire/ -- The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis.
  • Home dialysis is a form of renal (kidney) replacement therapy (aka, dialysis) that can be done at home by the patient alone or with the help of a care partner.
  • "Patients deserve to know about all options for dialysis so they can make an educated choice for themselves," said Kevin Longino, Chief Executive Officer of the National Kidney Foundation and a kidney transplant recipient.
  • "Policies like this make me increasingly optimistic that more kidney patients struggling with dialysis can have a chance to get some of their life back."

Meitheal Pharmaceuticals Announces Recent Business Progress Reinforcing Commitment to Sustainable Generics Development

Retrieved on: 
Tuesday, March 19, 2024

As we prepare to launch multiple new products in 2024, we are intently focused on expediting delivery of medicines in short supply,” said Tom Shea, Chief Executive Officer of Meitheal Pharmaceuticals.

Key Points: 
  • As we prepare to launch multiple new products in 2024, we are intently focused on expediting delivery of medicines in short supply,” said Tom Shea, Chief Executive Officer of Meitheal Pharmaceuticals.
  • As of March 1, 2024, both the U.S. Food and Drug Administration (FDA) and the American Society of Health-System Pharmacists (ASHP) websites list multiple presentations of Bupivacaine Hydrochloride Injection on drug shortage.
  • These approved lines add over 200 million units of capacity for vial and cartridge products that support current and future demand for generic injectables.
  • These lines are expected to produce commercial products that will have an impact on drug shortages beginning in the second half of 2024.

BLACK AMERICANS AT HIGHER RISK FOR KIDNEY FAILURE AS BLACK HEALTH MATTERS, NATIONAL KIDNEY FOUNDATION FIGHT FOR EQUITY DURING NATIONAL KIDNEY MONTH

Retrieved on: 
Thursday, March 14, 2024

NEW YORK, March 14, 2024 /PRNewswire/ -- Black Health Matters (BHM)– a leading nonprofit health advocacy organization that provides health and wellness information that is rooted in medical expertise to the Black community – is partnering with the National Kidney Foundation (NKF) to spread awareness about kidney equity during National Kidney Month. Observed in March each year, National Kidney Month aims to raise awareness about kidney health and chronic kidney disease. The month also includes World Kidney Day – a global health awareness day focusing on the importance of kidneys and the impact of kidney disease - which is observed March 14.

Key Points: 
  • Observed in March each year, National Kidney Month aims to raise awareness about kidney health and chronic kidney disease.
  • The month also includes World Kidney Day – a global health awareness day focusing on the importance of kidneys and the impact of kidney disease - which is observed March 14.
  • NKF continues to fight to get Kidney Equity for All - a commitment to make a difference in ALL kidney patients' lives!
  • "As an organization that spotlights health disparities and the importance of health in the Black community, kidney health has become a silent epidemic in our community," said Roslyn Young-Daniels, President, and Founder of Black Health Matters.

National Kidney Foundation Recognizes March as National Kidney Month

Retrieved on: 
Thursday, February 29, 2024

NEW YORK, Feb. 29, 2024 /PRNewswire/ -- As March approaches, the National Kidney Foundation (NKF) is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease (CKD). With World Kidney Day falling on Thursday, March 14th, this month holds particular significance in advocating for KIDNEY EQUITY FOR ALL™.

Key Points: 
  • NEW YORK, Feb. 29, 2024 /PRNewswire/ -- As March approaches, the National Kidney Foundation (NKF) is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease (CKD).
  • With World Kidney Day falling on Thursday, March 14th, this month holds particular significance in advocating for KIDNEY EQUITY FOR ALL™ .
  • "Despite this, they are exposed to inequities in kidney care including evaluation and obtaining a kidney transplant.
  • To mark National Kidney Month and World Kidney Day, NKF is highlighting several ways the organization is promoting kidney equity.

Six Tips for Dating while on Dialysis

Retrieved on: 
Wednesday, February 14, 2024

NEW YORK, Feb. 14, 2024 /PRNewswire/ -- Half of Americans think dating has gotten harder in the last ten years.1 Where does that leave someone looking for love with a serious illness, such as kidney failure? Dating is hard enough without the stress of treatments like dialysis. You may ask if dating can even be done when you have a major health condition. The answer is yes, dating on dialysis can absolutely be done. While chronic illness may make the logistics of dating a little more difficult, you are still capable of loving and deserving of love. Just in time for Valentine's Day, the National Kidney Foundation (NKF) is suggesting six tips to help anyone navigating the dating world while dealing with the stress of dialysis. 

Key Points: 
  • Dating is hard enough without the stress of treatments like dialysis.
  • The answer is yes, dating on dialysis can absolutely be done.
  • Just in time for Valentine's Day, the National Kidney Foundation (NKF) is suggesting six tips to help anyone navigating the dating world while dealing with the stress of dialysis.
  • For Valentine's Day, the NKF is suggesting six tips for anyone navigating the dating world while dealing with dialysis.

National Kidney Foundation Innovation Fund Invests in ImmunoFree

Retrieved on: 
Tuesday, January 30, 2024

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund. The fund will support ImmunoFree, a pioneering biomedical company dedicated to reshaping the landscape of organ transplantation by eliminating the need for immunosuppressive medications.

Key Points: 
  • ~
    NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund.
  • "In a post COVID world, solving the issues raised by immunosuppressive medications for transplant patients has never been more critical," said Kevin Longino, CEO of the National Kidney Foundation and a kidney transplant recipient.
  • Launched in 2021, the NKF Innovation Fund works to accelerate funding, development, and commercialization of therapies that kidney patients need and deserve.
  • The fund invests in early to mid-stage companies that are developing innovative, patient-centric kidney therapies.

Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones

Retrieved on: 
Tuesday, January 23, 2024

LOS ALTOS, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today issued a letter to shareholders.

Key Points: 
  • As I sit down to write this letter, I am filled with a profound sense of gratitude and excitement, energized for the year ahead.
  • In this letter, I am pleased to recap for you another year of great accomplishments.
  • We’ve made significant advancements in our clinical programs which will propel us to new heights in 2024.
  • I would like to express my deep appreciation to the physician investigators, study participants, and especially to our dedicated Unicycive employees.

CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024

Retrieved on: 
Friday, December 1, 2023

The Patient Activation Measure (PAM) measures a patient’s knowledge, skills and confidence to self-manage their health.

Key Points: 
  • The Patient Activation Measure (PAM) measures a patient’s knowledge, skills and confidence to self-manage their health.
  • Activated patients feel comfortable advocating for themselves and asking for support from their care team to manage their own health.
  • “It’s incredibly gratifying to see CMS include the Patient Activation Measure Performance Measure in its program as a high priority outcome measure.
  • “As a practice that uses the Patient Activation Measure and participates in MIPS, we're incredibly excited to see that PAM will be a MIPS measure going forward.

New Study Finds Significant Impact of Plant-Based Diets on Chronic Kidney Disease Patients

Retrieved on: 
Friday, December 15, 2023

NKF's AJKD study reveals that a healthy plant-based diet will reduce the risk of all-cause mortality in CKD patients.

Key Points: 
  • NKF's AJKD study reveals that a healthy plant-based diet will reduce the risk of all-cause mortality in CKD patients.
  • This study suggests that plant-based diets can be a viable and beneficial dietary option for CKD patients.
  • It also emphasizes the importance of dietary quality by distinguishing between overall plant-based diets, healthy plant-based diets, and unhealthy plant-based diets.
  • The study, which involved 2,539 participants with CKD from the Chronic Renal Insufficiency Cohort (CRIC) study, conducted between 2003 and 2008, sheds light on the impact of dietary choices in CKD patients.